Duk-Jae Oh

Duk-Jae Oh serves as Professor in the Department of Integrative Bioscience and Biotechnology at Sejong University since 2001, with additional leadership roles including Dean of Planning and Budgeting (2008-2009), Chair of AFOB's Financial Committee (2010-present), and Korea's Representative Delegate for ISO/TC276 Biotechnology Working Group 4 (2015-present).

Education:

• Ph.D. from KAIST (1992)
• M.S. from KAIST (1988)
• B.S. from Seoul National University (1986)

Research Focus: Professor Oh pioneers animal cell technology for biopharmaceutical production including gene therapy vectors, cell therapies, and therapeutic proteins. His expertise spans bioreactor engineering, cell culture process optimization, and recombinant cell line development, with major contributions to perfusion systems and single-use bioreactor technologies.

Publication Trends: Recent 2024 work demonstrates innovation in orbital rocking motion bioreactors (CELBIC®) and funnel-type fluidized bed systems, advancing adherent cell culture scalability. Earlier studies (2014-2020) systematically address glycosylation control in antibody production and gas-permeable membrane devices, establishing foundational principles for bioprocess consistency in therapeutic protein manufacturing.

Scientific Recognition: With 30 research outputs and 420 citations (h-index 14), his work is referenced in 1 patent though no formal awards are documented.

Research Leadership: His administrative roles in AFOB and ISO/TC276 reflect international standing in bioprocessing standards development, though specific grant funding details and student mentorship records are not provided in available materials.

Technical Infrastructure: Research activities center on bioprocess engineering facilities at Sejong University, with fingerprint analysis indicating deep specialization in perfusion systems (100%), recombinant antibody production (76%), and Chinese hamster ovary cell technologies (55%).